Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker.
about
Toxicity of MRI and CT contrast agentsDynamic contrast enhanced MRI detects early response to adoptive NK cellular immunotherapy targeting the NG2 proteoglycan in a rat model of glioblastomaHydrogels to model 3D in vitro microenvironment of tumor vascularizationFrom bench to bedside: lessons learned in translating preclinical studies in cancer drug developmentSensitivity of MRI tumor biomarkers to VEGFR inhibitor therapy in an orthotopic mouse glioma modelWhole animal imaging.Monitoring antivascular therapy in head and neck cancer xenografts using contrast-enhanced MR and US imagingAngiogenic inhibition in high-grade gliomas: past, present and future.Translational imaging endpoints to predict treatment response to novel targeted anticancer agents.Intravascular targets for molecular contrast-enhanced ultrasound imagingTheragnostics for tumor and plaque angiogenesis with perfluorocarbon nanoemulsionsPET/MRI for neurologic applications.Functional imaging in adult and paediatric brain tumours.Water exchange-minimizing DCE-MRI protocol to detect changes in tumor vascular parameters: effect of bevacizumab/paclitaxel combination therapy.Dynamic contrast-enhanced MRI: Study of inter-software accuracy and reproducibility using simulated and clinical data.Evaluation of the effect of transcytolemmal water exchange analysis for therapeutic response assessment using DCE-MRI: a comparison studyMRI for identification of progression in brain tumors: from morphology to function.Targeting hypoxia-inducible factor-1α (HIF-1α) in combination with antiangiogenic therapy: a phase I trial of bortezomib plus bevacizumabTumor vascular permeability to a nanoprobe correlates to tumor-specific expression levels of angiogenic markers.Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme.Imaging and 'omic' methods for the molecular diagnosis of cancer.MRI biomarkers identify the differential response of glioblastoma multiforme to anti-angiogenic therapy.Mechanistic modelling of dynamic MRI data predicts that tumour heterogeneity decreases therapeutic response.DCE-MRI Background Parenchymal Enhancement Quantified from an Early versus Delayed Post-contrast Sequence: Association with Breast Cancer Presence.Automatic Segmentation of Breast Carcinomas from DCE-MRI using a Statistical Learning AlgorithmSTEP: spatiotemporal enhancement pattern for MR-based breast tumor diagnosis.Tumor metabolism and perfusion in head and neck squamous cell carcinoma: pretreatment multimodality imaging with 1H magnetic resonance spectroscopy, dynamic contrast-enhanced MRI, and [18F]FDG-PET.Antiangiogenic effects of pazopanib in xenograft hepatocellular carcinoma models: evaluation by quantitative contrast-enhanced ultrasonography.Noninvasive assessment of tumor microenvironment using dynamic contrast-enhanced magnetic resonance imaging and 18F-fluoromisonidazole positron emission tomography imaging in neck nodal metastases.Vascular effects, efficacy and safety of nintedanib in patients with advanced, refractory colorectal cancer: a prospective phase I subanalysisNon-invasive imaging of angiogenesis in head and neck squamous cell carcinomaTargeted therapies in renal cell cancer: recent developments in imagingDynamic contrast-enhanced magnetic resonance imaging of sunitinib-induced vascular changes to schedule chemotherapy in renal cell carcinoma xenograft tumors.Correlation of a priori DCE-MRI and (1)H-MRS data with molecular markers in neck nodal metastases: Initial analysis.Temporal/spatial resolution improvement of in vivo DCE-MRI with compressed sensing-optimized FLASHEffect of the enhancement threshold on the computer-aided detection of breast cancer using MRI.Quantification of antiangiogenic and antivascular drug activity by kinetic analysis of DCE-MRI data.Functional dynamic contrast-enhanced magnetic resonance imaging in an animal model of brain metastases: a pilot study.Synthesis and characterization of a hypoxia-sensitive MRI probeA multichannel Markov random field framework for tumor segmentation with an application to classification of gene expression-based breast cancer recurrence risk.
P2860
Q22306013-5A4F4ACA-B696-438B-B93B-83D5CD68A26DQ27344690-74E2E5BA-34D4-489B-852F-B405E7995AA6Q28383786-34EBE5B3-5C1A-49DE-88C8-46EE5BE606AFQ28533949-9AEAED1C-545F-49B0-B129-3173A8D873A1Q28742242-0444460D-F80E-47E7-9474-72801D6F5486Q30411800-8F5E8690-8181-4857-ABAC-70127C582AFAQ30452632-FE05C93E-CB88-4D67-ABE2-52817AC64716Q30455596-3ED80CF8-D5E9-497C-957A-E8EDBE80AC68Q30465097-D96E721D-5A7A-46DB-B0F2-7637510CE374Q30465487-B9C41513-92D4-44BD-B159-E8986705E7D5Q30474759-AA903205-2EA3-4B88-BB39-7C24D2E1764EQ30577115-721AD169-4B12-4598-B40E-1F2E52A86410Q30577397-481AC6DA-712E-463A-BAF7-7F9C251352C4Q30651989-95685B37-7ED4-44DB-99FC-E34C9A0093B8Q31033043-54E77FBA-B73E-4D51-A574-8FB9633C71C0Q31106171-169986A9-5946-4B69-8CA5-6E3721842840Q33377547-158EFB91-6106-43E8-9D95-2019CF3CB46BQ33418562-B0A15F0C-C28D-4100-94F7-50173E9E5A84Q33464944-268C470B-AA3F-49A0-A42D-98A3D3816C80Q33518926-140A91FA-C928-41CF-A0AB-366B70402E84Q33577268-71414F62-2EF4-4C6E-87C7-738608341557Q33616649-97D412E7-C71A-4818-AB1E-1DA61131DED3Q33632105-2268908B-EEC6-4860-B4E1-E0DD88C22FFBQ33704986-D31C1C25-3DAB-4D6A-B872-72F14B028FFFQ33777921-33748C3D-F73C-4BB6-BCA5-86428DE8D856Q33780623-35442A40-E71C-42C2-8F07-32FA667A117CQ33793870-A8E70DD3-5CB1-4C9C-B201-D8359203691EQ33798661-B057759D-6DDF-4A1C-A04E-CC430A74D22EQ33925417-78A51FA1-B44F-465C-B166-F745504196C8Q33926377-66F4CFFD-1634-4DC8-85B5-A8E874CE7559Q34029591-BCB399DE-34F6-4DB8-A0CE-B3AB595F8E75Q34088696-23463052-45BE-495A-99C8-AF63F8F8455EQ34111200-BF60DE99-D6C7-40D0-B9C1-633346100002Q34172445-DB7D6B21-057F-462B-93E9-27470E0F41E2Q34215586-71A3D755-E5DB-42D0-9B3C-5001692D1299Q34258300-7125538F-80F9-4856-8327-30A03C386994Q34269947-26913670-909F-40FF-9242-05B0776CFE34Q34287393-ED96D7A2-3E2C-4A07-8720-F1919F0769D8Q34319457-8EF6D4EE-6587-405A-99BA-87DCEAC8C94FQ34342315-E365D257-136C-4606-ABBC-2ED1BBF34BF4
P2860
Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker.
@ast
Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker.
@en
type
label
Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker.
@ast
Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker.
@en
prefLabel
Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker.
@ast
Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker.
@en
P356
P1476
Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker.
@en
P2093
Nola Hylton
P304
P356
10.1200/JCO.2006.06.8080
P407
P577
2006-07-01T00:00:00Z